CAR T-Cell Therapy.A New Way to Fight Cancer.
Explore leading U.S. CAR T-cell programs for eligible blood cancers, with physician-led guidance to identify the right specialists, centers, and treatment pathways.
Immune Cells
Targeting
Treatment
Every Patient
Advanced Immunotherapy
Helping eligible patients access leading CAR T-Cell programs at renowned U.S. cancer centers.
CAR T-Cell Therapy:
Your Immune Cells,
Reengineered to Fight Cancer.
CAR T-cell therapy is a form of cancer immunotherapy that modifies a patient's own T cells to recognize specific targets on cancer cells. The engineered cells are expanded and returned to the patient, where they can identify and attack targeted cancer cells.
Currently used primarily for certain blood cancers, CAR T-cell therapy is also being studied for additional cancers through clinical trials.
Uses Your Own
Immune Cells
Personalized from your blood
Engineered to
Recognize Cancer
Targets specific cancer cells
Expanded &
Reinfused
Millions of cells grown in a lab
Designed to
Attack Cancer
Seeks out and destroys targeted cancer cells
Could CAR T-Cell Therapy
Be an Option for Your Cancer?
CAR T-cell therapies are approved for several blood cancers,
while new CAR-T approaches are being investigated through clinical trials.
Certain Lymphomas
DLBCL • Follicular lymphoma • Mantle cell lymphoma • Other eligible B-cell lymphomas
Multiple Myeloma
BCMA-targeted CAR-T options for selected patients.
Acute Lymphoblastic Leukemia
CAR-T options for eligible B-cell ALL patients.
Chronic Lymphocytic Leukemia
CAR-T options may be available for selected patients.
Solid Tumors — Clinical Trials
Investigational CAR-T approaches are being studied for selected solid tumors.
Eligibility depends on your diagnosis, prior treatments, and individual evaluation.
Our team will help you explore the right options.
The Right CAR-T Pathway
Starts With the Right Match.
Your diagnosis, biomarkers, prior treatments and disease status help determine which CAR-T options and U.S. programs may be relevant to your case.
DIAGNOSIS
We review your diagnosis and treatment history in detail.
MEDICAL & MOLECULAR REVIEW
Our experts evaluate your records, biomarkers, and prior therapies.
CAR-T ELIGIBILITY
We determine potential eligibility for approved CAR-T therapies or clinical trials.
U.S. PROGRAM / CLINICAL TRIAL MATCH
We identify the most appropriate U.S. CAR-T programs and specialists for your case.
ACCESS & COORDINATION
We handle appointments, records, travel support, and ongoing care coordination.
DIAGNOSIS
We review your diagnosis and treatment history in detail.
MEDICAL & MOLECULAR REVIEW
Our experts evaluate your records, biomarkers, and prior therapies.
CAR-T ELIGIBILITY
We determine potential eligibility for approved CAR-T therapies or clinical trials.
U.S. PROGRAM / CLINICAL TRIAL MATCH
We identify the most appropriate U.S. CAR-T programs and specialists for your case.
ACCESS & COORDINATION
We handle appointments, records, travel support, and ongoing care coordination.
How CAR T-Cell Therapy Is Made
Your T cells are collected, engineered, expanded, and returned to your body.
Collection
From your blood
T cells are collected from your blood through a process called leukapheresis.
Engineering
Reprogrammed to find and fight cancer
T cells are genetically modified in a lab to add a CAR (chimeric antigen receptor) that helps them recognize cancer cells.
Expansion
Grown into millions of warriors
Engineered T cells are multiplied in the lab to create millions of CAR T cells ready for infusion.
Infusion
Back to you
The engineered CAR T cells are infused back into your body, where they can find and attack cancer cells.
Each CAR T-cell therapy is unique and may take several weeks from cell collection to infusion. Our team will guide and support you at every step.
World-Class CAR-T Expertise.
One Coordinated Path.
MediPocket helps patients navigate appropriate CAR-T programs across leading U.S. cancer centers based on diagnosis and eligibility.
MediPocket is an independent care navigation company. We are not owned or operated by any of the hospitals listed above. Our team helps you navigate and access the right programs for your unique case.
Approved or Investigational,
We'll Help You Find What's Right.
Whether an FDA-approved therapy or a clinical trial is the right path, MediPocket helps you explore every appropriate option.
Established CAR-T therapies are available for eligible patients with certain leukemias, lymphomas and multiple myeloma.
Research is expanding CAR-T into new targets, earlier treatment settings and selected solid tumors.
Our team evaluates your case to determine the most appropriate pathway for your diagnosis and goals.
Why Patients Choose MediPocket
We make complex care simpler—connecting you to the right CAR-T experts, programs and support in the U.S.
Physician-Led Case Review
Your diagnosis and treatment history guide the search.
U.S. Program Matching
We identify relevant specialists, centers and research pathways.
Cross-Border Coordination
Records, appointments, medical visa support and travel coordination.
One Dedicated Care Navigator
One point of coordination throughout your U.S. care journey.
When the Right Treatment
Changes What's Possible.
Real patients. Real journeys. Coordinated care that opens new possibilities.
MediPocket helped us understand every option and connected us to a leading CAR-T program in the U.S. The care our son received gave us hope—and a future.
After years of treatments that stopped working, CAR-T changed everything. MediPocket made the complex process simple and stress-free.
We explored clinical trials when approved options were not available. MediPocket found the right trial at the right time for my father.
From records and appointments to travel and stay, MediPocket coordinated everything seamlessly. We could focus on what mattered most—her recovery.
The MediPocket team was with us at every step. Their guidance helped us find the right specialists and the right treatment for my husband.
CAR T-Cell Therapy FAQs
Answers to the most important questions patients and families ask when considering CAR-T treatment in the U.S.
Still Have Questions?
Our team is here to provide clarity and help you understand your best next steps.
Could CAR-T Be the
Right Next Step?
Every case is different. Share your diagnosis and treatment history, and our team will help identify relevant U.S. CAR-T programs and clinical trial pathways to explore.
REQUEST A CAR-T CASE REVIEW
Tell us about your case. We'll help you understand what options may be worth exploring.
CAR-T eligibility and treatment decisions are determined by the treating institution and clinical team. MediPocket provides independent care navigation and coordination and does not provide CAR-T treatment.